Esaote foresees new applications for Artoscan
This article was originally published in Clinica
Executive Summary
Esaote Biomedica is evaluating the clinical potential of its Artoscan limb and joint MRI system in diagnosing breast lesions. The Italian company also revealed, in the prospectus it issued for its recent heavily oversubscribed share offering, that it is investigating the product's suitability for shoulder examinations. Esaote had sold over 140 Artoscans by December 1995, 70% in international markets.